Khurram Jamil, Chief Medical Officer: Galectin Therapeutics GALT Sell · Filed 01/05

Trade details

Type: Insider sale
Amount: $33,068.75
Shares · price: 8,125 sh · $4.07 a share
Held after: 0 sh
Stock: Galectin Therapeutics GALT
Person: Khurram JamilChief Medical Officer
Trade date: 25/12/31
Filed: 26/01/05
Days to filing: 5 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Galectin Therapeutics trades, last 26 weeks

What else happened in Galectin Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

Khurram Jamil's recent trades

Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$239.2K
47,467 sh
$239.2K
Filed 06/30
Traded 06/29
Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$12.7K
2,533 sh
$12.7K
Filed 06/30
Traded 06/26
Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$10.2K
2,037 sh
$10.2K
Filed 06/30
Traded 06/26
Khurram JamilChief Medical Officer
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$341.4K
68,287 sh
$341.4K
Filed 06/26
Traded 06/26
Khurram JamilChief Medical Officer
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$23.7K
7,557 sh
$23.7K
Filed 06/25
Traded 06/23